Home / Intelligence / Webinars / Health Equity in HTA Outcomes: Navigating the New Frontier
April 30, 2025 | 11:00 - 11:45 AM ET / 17:00 - 17:45 CET
A second session will be offered: May 1 at 16:00-16:45 (UTC +8:00) – Asia/Shanghai
Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.
This session will explore how HTA agencies are beginning to include health equity in their access recommendations and discuss the practical impact of this trend. Our experts will share insights from Trinity Life Sciences’ Value Center of Excellence on incorporating the work of health equity teams into access materials in a way that moves the needle for payers.
Key Webinar Topics
- The prevalence of health equity considerations in HTA outcomes
- Practical steps to incorporate health equity into access materials
- The importance of health equity compared to other factors
- Emerging value drivers in the industry
Spotlight Speakers
Max Hunt
Partner,
Value, Access & Pricing
Mary Fletcher-Louis
Managing Director &
Head of Value Center of Excellence
Pinar Bilir
Managing Director,
Evidence, Value, Access & Pricing
Which session would you like to register for?
Complete the form below to register for the April 30th session at 11:00 AM ET
Complete the form below to register for the May 1st session at 16:00 UTC+8 – Asia/Shanghai
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Webinars
Virtual Demo | HTA Vision with GenAI
Available On Demand
Join Trinity Life Sciences for a virtual demo where value, access and pricing experts Max Hunt and Andreia Ribeiro will demonstrate Trinity HTA Vision, our cloud-based dashboard with GenAI capabilities. It is not enough to know what the health technology assessment (HTA) decisions are and when they are made—with the landscape continually evolving, analogues and future […]
Watch Now
Blog
Learnings to Kick-Start 2025: Health Equity
Health equity continues to be a hot topic in the life sciences industry. ISPOR EU sessions addressed several key questions surrounding the impact of health equity on HTA decision-making, the methodologies that should be employed, and the opportunities and challenges of incorporating health equity into health technology assessment (HTA). Ahead of ISPOR EU, Trinity’s HTA […]
Read More
Blog
Maximum Fair Price Round 2: Passing the Baton
On January 20, 2025, CMS announced the set of fifteen drugs targeted for the second round of Maximum Fair Price (MFP) “negotiations” under IRA. With the outcomes of the first price “negotiations” announced only last August, the IRA MFP process is still in its early development and there remains uncertainty over how it will evolve […]
Read More